Toll-like receptor 4 blocker as potential therapy for acetaminophen-induced organ failure in mice

Experimental and Therapeutic Medicine

Volumn 10, Issue 1, 2015, Pages 241-246

  Salama, Mohamed ^a   Elgamal, Mohamed ^a   Abdelaziz, Azza ^b   Ellithy, Moataz ^a   Magdy, Dina ^a   Ali, Lina ^a   Fekry, Emad ^a   Mohsen, Zinab ^a   Mostafa, Mariam ^a   Elgamal, Hoda ^a   Sheashaa, Hussein ^c   Sobh, Mohamed ^a,c  

^a MANSOURA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

^c MANSOURA UNIVERSITY   (Egypt)

Author keywords

Acetaminophen; Hepatotoxicity; Nephrotoxicity; Toll like receptor 4

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; GLUTATHIONE; PARACETAMOL; TOLL LIKE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ASSAY; HISTOLOGY; HISTOPATHOLOGY; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PROTEIN BINDING;

EID: 84929610349     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2442     Document Type: Article

References (25)

1. Abboud G and Kaplowitz N: Drug‑induced liver injury. Drug Saf 30: 277‑294, 2007.
2. Tujios S and Fontana RJ: Mechanisms of drug‑induced liver injury: From bedside to bench. Nat Rev Gastroenterol Hepatol 8: 202‑211, 2011.
3. Nourjah P, Ahmad SR, Karwoski C and Willy M: Estimates of acetaminophen (Paracetomal)‑associated overdoses in the United States. Pharmacoepidemiol Drug Saf 15: 398‑405, 2006.
4. Mitchell JR, Jollow DJ, Potter WZ, Gillette JR and Brodie BB: Acetaminophen‑induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 187: 211‑217, 1973.
5. Terneus MV, Kiningham KK, Carpenter AB, Sullivan SB and Valentovic MA: Comparison of S‑adenosyl‑L‑methionine and N‑acetylcysteine protective effects on acetaminophen hepatic toxicity. J Pharmacol Exp Ther 320: 99‑107, 2007.
6. Cermik H, Taslipinar MY, Aydin I, et al: The relationship between N‑acetylcysteine, hyperbaric oxygen and inflammation in a rat model of acetaminophen‑induced nephrotoxicity. Inflammation 36: 1145‑1152, 2013.
7. McGill MR and Jaeschke H: Metabolism and disposition of acetaminophen: Recent advances in relation to hepatotoxicity and diagnosis. Pharm Res 30: 2174‑2187, 2013
8. Jaeschke H, McGill MR and Ramachandran A: Oxidant stress, mitochondria and cell death mechanisms in drug‑induced liver injury: Lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev 44: 88‑106, 2012.
9. Jaeschke H and Bajt ML: Intracellular signaling mechanisms of acetaminophen‑induced liver cell death. Toxicol Sci 89: 31‑41, 2006.
10. Arslan F, Keogh B, McGuirk P and Parker AE: TLR2 and TLR4 in ischemia reperfusion injury. Mediators Inflamm 2010: 704, 2010.
11. Zager RA, Johnson AC, Lund S and Randolph‑Habecker J: Toll like receptor (TLR4) shedding and depletion: acute proximal tubular cell responses to hypoxic and toxic injury. Am J Physiol. Renal Physiol 292: F304‑F312, 2007.
12. Hayashi F, Smith KD, Ozinsky A, et al: The innate immune response to bacterial flagellin is mediated by Toll‑like receptor 5. Nature 410: 1099‑1103, 2001.
13. Kobayashi K, Hernandez LD, Galán JE, Janeway CA Jr, Medzhitov R and Flavell RA: IRAK‑M is a negative regulator of Toll‑like receptor signaling. Cell 110: 191‑202, 2002.
14. Daubeuf B, Mathison J, Spiller S, et al: TLR4/MD‑2 monoclonal antibody therapy affords protection in experimental models of septic shock. J Immunol 179: 6107‑6114, 2007.
15. Kanzler H, Barrat FJ, Hessel EM and Coffman RL: Therapeutic targeting of innate immunity with Toll‑like receptor agonists and antagonists. Nat Med 13: 552‑559, 2007.
16. Xu J, Zhang X, Monestier M, Esmon NL and Esmon CT: Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. J Immunol 187: 2626‑2631, 2011.
17. Valentovic M, Terneus M, Harmon RC and Carpenter AB: S‑Adenosylmethionine (SAMe) attenuates acetaminophen hepatotoxicity in C57BL/6 mice. Toxicol Lett 154: 165‑174, 2004.
18. Kao LW, Kirk MA, Furbee RB, Mehta NH, Skinner JR and Brizendine EJ: What is the rate of adverse events after oral N‑acetylcysteine administered by the intravenous route to patients with suspected acetaminophen poisoning? Ann. Emerg Med 42: 741‑750, 2003.
19. Shah N, Montes de Oca M, Jover‑Cobos M, et al: Role of toll‑like receptor 4 in mediating multiorgan dysfunction in mice with acetaminophen induced acute liver failure. Liver Transpl 19: 751‑761, 2013.
20. Salama M, Farrag SM, Abulasrar SA, et al: Up‑regulation of TLR‑4 in the brain after ischemic kidney‑induced encephalopathy in the rat. CNS Neurol Disord Drug Targets 12: 583‑586, 2013.
21. Hartley DP, Kolaja KL, Reichard J and Petersen DR: 4‑Hydroxynonenal and malondialdehyde hepatic protein adducts in rats treated with carbon tetrachloride: Immunochemical detection and lobular localization. Toxicol Appl Pharmacol 161: 23‑33, 1999.
22. Chan JK, Roth J, Oppenheim JJ, et al: Alarmins: Awaiting a clinical response. J Clin Invest 122: 2711‑2719, 2012.
23. Lugrin J, Rosenblatt‑Velin N,Parapanov R andLiaudet L: The role of oxidative stress during inflammatory processes. Biol Chem 395: 203‑230, 2014.
24. Latorre E, Mendoza C, Layunta E, Alcalde AI and Mesonero JE: TLR2, TLR3 and TLR4 activation specifically alters the oxidative status of intestinal epithelial cells. Cell Stress Chaperones 19: 289‑293, 2014.
25. Pierre N, Deldicque L, Barbé C, Naslain D, Cani PD and Francaux M: Toll‑like receptor 4 knockout mice are protected against endoplasmic reticulum stress induced by a high‑fat diet. PLoS One 8: e65061, 2013.